Considering the continued focus on quality over quantity and the rise of online reviews, patient experience has never been more important in healthcare than it is today. A new study published by Radiology tracked one radiology department’s efforts to assess its own patient experience, identify improvement opportunities and make a difference.
Digital breast tomosynthesis (DBT) implementation in a diagnostic setting can result in an improved cancer detection rate (CDR) and more accurate biopsy recommendations, according to a new case study published in the Journal of the American College of Radiology.
Providing pediatric patients with MRI scans without anesthesia is an example of patient- and family-centered care (PFCC) in action, according to new research published in the Journal of Radiology Nursing. The authors found that this practice can lead to lower healthcare costs and shorter procedure times.
Invasive lobular, low-grade and HER-2-negative breast cancers are more detectable with digital breast tomosynthesis (DBT) than full-field digital mammography (FFDM) when imaging patients with dense breasts, according to a new study published in the Korean Journal of Radiology.
Hoping to make worthwhile MRI workflow improvements? Extracting DICOM metadata can provide more accurate, reliable information than RIS data alone, according to findings published in the Journal of Digital Imaging.
Stationary digital breast tomosynthesis (sDBT), which allows views to be collected without moving the x-ray tube, leads to improved reader accuracy compared to mammography, according to new findings published in Academic Radiology.
Radiologists provide significant value. According to a new analysis published in the Journal of the American College of Radiology, however, the specialty is still judged by “checkbox metrics” that do not illustrate its true value.
Treating pediatric Hodgkin lymphoma (HL) patients with chemotherapy followed by radiotherapy results in a better five-year survival rate than chemotherapy alone, according to new findings published in JAMA Oncology.
The overall cancer death rate in the United States has dropped 27 percent in the last 25 years, according to a new report from the American Cancer Society (ACS). This means approximately 2.6 million fewer people have died from cancer during that time.